Loading…
18F–FDG-PET/CT Angiography for the Diagnosis of Infective Endocarditis
Purpose of Review This article reviews the current imaging role of 18 F–fluordeoxyglucose positron emission computed tomography ( 18 F–FDG-PET/CT) combined with cardiac CT angiography (CTA) in infective endocarditis and discusses the strengths and limitations of this technique. Recent Findings The d...
Saved in:
Published in: | Current cardiology reports 2017-02, Vol.19 (2), p.15-15, Article 15 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Purpose of Review
This article reviews the current imaging role of
18
F–fluordeoxyglucose positron emission computed tomography (
18
F–FDG-PET/CT) combined with cardiac CT angiography (CTA) in infective endocarditis and discusses the strengths and limitations of this technique.
Recent Findings
The diagnosis of infective endocarditis affecting prosthetic valves and intracardiac devices is challenging because echocardiography and, therefore, the modified Duke criteria have well-recognized limitations in this clinical scenario. The high sensitivity of
18
F–FDG-PET/CT for the detection of infection associated with the accurate definition of structural damage by gated cardiac CTA in a combined technique (PET/CTA) has provided a significant increase in diagnostic sensitivity for the detection of IE.
Summary
PET/CTA has proven to be a useful diagnostic tool in patients with suspected infective endocarditis. The additional information provided by this technique improves diagnostic performance in prosthetic valve endocarditis when it is used in combination with the Duke criteria. The findings obtained in PET/CTA studies have been included as a major criterion in the recently updated diagnostic algorithm in infective endocarditis guidelines. |
---|---|
ISSN: | 1523-3782 1534-3170 |
DOI: | 10.1007/s11886-017-0824-3 |